Pancreatic Cancer Research

ResearcherShiga University of Medical ScienceActive in the last 2 years

Sachiko Kaida

Matched on ORCID iD 0000-0002-1279-5942; OpenAlex author ID A5046105983, A5153826601. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: 2 papers · 2025: 2 papers · 2026: 2 papers

Papers 8

  1. Painful penile erection as a manifestation of metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s12328-025-02278-w↗
  2. Temporary Mesocaval Bypass During Pancreaticoduodenectomy for Pancreatic Cancer With Portal Vein Occlusion: A Case Report. Last author DOI 10.21873/anticanres.18419↗
  3. Preoperative Predictive Nomogram (DASINEL Score) for Early Recurrence in Pancreatic Cancer. Co-author DOI 10.21873/anticanres.17737↗
  4. Dynamic changes in tumor blood flow during chemotherapy: Implications in customized treatment for pancreatic cancer. Co-author DOI 10.3892/ol.2025.15325↗
  5. Clinical impact of the prognostic nutritional index and skeletal muscle index for the incompletion of adjuvant chemotherapy for pancreatic cancer. Co-author DOI 10.1016/j.asjsur.2024.10.151↗
  6. [A Case of Needle Tract Seeding Discovered Three Years after Pancreatic Cancer Surgery and Treated with Local Gastrectomy]. Co-author PMID 39948921↗
  7. Estimated tumor blood flow as a predictive imaging indicator of therapeutic response in pancreatic ductal adenocarcinoma: use of three-phase contrast-enhanced … Co-author DOI 10.1007/s10147-021-02066-9↗
  8. A High C-Reactive Protein Level on Postoperative Day 7 Is Associated With Poor Survival of Patients With Pancreatic Ductal Adenocarcinoma After Resection. Last author DOI 10.1177/00031348211023406↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haruki Mori · 8 shared papers, 2022–2026 · strength 1.78
  2. Hiromitsu Maehira · 8 shared papers, 2022–2026 · strength 1.78
  3. Masaji Tani · 7 shared papers, 2022–2026 · strength 1.47
  4. Seiya Naito · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.